Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
International Journal of Thyroidology ; : 190-194, 2016.
Article in English | WPRIM | ID: wpr-134001

ABSTRACT

A 22-year-old woman with severe Graves' disease was referred from a local clinic because of her refractory hyperthyroidism. She presented with exophthalmos, diffuse goiter, and tachycardia. She was treated with a maximal dose of methimazole and a beta-blocker for 2 months. However, her thyroid function test (TFT) did not improve. TFT showed a free T4 level of 74.7 ng/dL and a thyroid stimulating hormone (TSH) level of 0.007 µIU/mL. She was then administered cholestyramine (4 g thrice daily), hydrocortisone (300 mg/day) and methimazole (100 mg/day) which prepared the patient for surgery by reducing the free T4 level (4.7 ng/dL). The patient underwent a total thyroidectomy without experiencing thyrotoxic crisis. This case describes the use of cholestyramine for the first time in Korea in treating Graves' disease and provides limited evidence that cholestyramine can be an effective option.


Subject(s)
Female , Humans , Young Adult , Cholestyramine Resin , Exophthalmos , Goiter , Graves Disease , Hydrocortisone , Hyperthyroidism , Korea , Methimazole , Tachycardia , Thyroid Crisis , Thyroid Function Tests , Thyroidectomy , Thyrotoxicosis , Thyrotropin
2.
International Journal of Thyroidology ; : 190-194, 2016.
Article in English | WPRIM | ID: wpr-134000

ABSTRACT

A 22-year-old woman with severe Graves' disease was referred from a local clinic because of her refractory hyperthyroidism. She presented with exophthalmos, diffuse goiter, and tachycardia. She was treated with a maximal dose of methimazole and a beta-blocker for 2 months. However, her thyroid function test (TFT) did not improve. TFT showed a free T4 level of 74.7 ng/dL and a thyroid stimulating hormone (TSH) level of 0.007 µIU/mL. She was then administered cholestyramine (4 g thrice daily), hydrocortisone (300 mg/day) and methimazole (100 mg/day) which prepared the patient for surgery by reducing the free T4 level (4.7 ng/dL). The patient underwent a total thyroidectomy without experiencing thyrotoxic crisis. This case describes the use of cholestyramine for the first time in Korea in treating Graves' disease and provides limited evidence that cholestyramine can be an effective option.


Subject(s)
Female , Humans , Young Adult , Cholestyramine Resin , Exophthalmos , Goiter , Graves Disease , Hydrocortisone , Hyperthyroidism , Korea , Methimazole , Tachycardia , Thyroid Crisis , Thyroid Function Tests , Thyroidectomy , Thyrotoxicosis , Thyrotropin
SELECTION OF CITATIONS
SEARCH DETAIL